Clinical Trial Update: A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the tolerability and efficacy of cannabidiol for motor symptoms in Parkinson's disease has completed enrollment with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-07-23